Cargando…
Anti-angiogenic peptides application in cancer therapy; a review
Cancer is a disease advanced via surplus angiogenesis. The development of new anti-angiogenic therapeutic agents with more efficacy and fewer side effects is still quite necessary. Conventional therapies saving the life of many cancer patients but due to drug resistance and lack of specificity utili...
Autores principales: | Shoari, Alireza, Khodabakhsh, Farnaz, Ahangari Cohan, Reza, Salimian, Morteza, Karami, Elmira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562409/ https://www.ncbi.nlm.nih.gov/pubmed/34760005 http://dx.doi.org/10.4103/1735-5362.327503 |
Ejemplares similares
-
Designing and Development of a Tandem Bivalent Nanobody against VEGF(165)
por: Khodabakhsh, Farnaz, et al.
Publicado: (2021) -
Discovery of potential FGFR3 inhibitors via QSAR, pharmacophore modeling, virtual screening and molecular docking studies against bladder cancer
por: Ganji, Mahmoud, et al.
Publicado: (2023) -
pH-Responsive PEGylated Niosomal Nanoparticles as an Active-Targeting Cyclophosphamide Delivery System for Gastric Cancer Therapy
por: Khodabakhsh, Farnaz, et al.
Publicado: (2022) -
Biochemical and Biological Evaluation of an L-Asparaginase from Isolated Escherichia coli MF-107 as an Anti-Tumor Enzyme on MCF7 Cell Line
por: Shahnazari, Masoumeh, et al.
Publicado: (2022) -
Computational and nonglycosylated systems: a simpler approach for development of nanosized PEGylated proteins
por: Mirzaei, Hadi, et al.
Publicado: (2016)